Annotation Detail for KCNIP4

Basic Information
Top
Pathway ID | Pathway Name |
---|
200106 | Regulation of Wnt-mediated beta catenin signaling and target gene transcription |
Desease ID | Desease Name |
---|
1766 | Renal Cell cancer |
Desease Name |
---|
Suicidal ideation |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of KCNIP4 mRNA | decreases expression | 20406850
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.80 | 16705839 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.12 | 6135515 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.93 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
2.08 | 21346803 18551238 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.46 | 16705839 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.30 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.84 | 2876784 2876786 6135515 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.95 | 7678174 18551238 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
4.00 | 16049721 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.88 | 18551238 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.45 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
5.41 | 10091137 |
PharmGKB Accession:PA134893552
Releated disease ID |
Related disease Name |
PA443937 | Drug Toxicity |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
PA164925725 | Toxic liver disease |
Releated drug ID |
Related drug Name |
PA452621 | antineoplastic agents |